Atrial fibrillation recurrence

1. GLP-1 receptor agonists have no effect on atrial fibrillation recurrence in humans (HR 1.01, 95% CI 0.89-1.15).

   Humansadults undergoing catheter ablation for AF12 months prior to CA

   The Effect of Glucagon-Like Peptide-1 Receptor Agonists versus Sodium-Glucose Cotransporter-2 Inhibitors Alone and in Combination on AF Recurrence and Cardiovascular Outcomes after Catheter Ablation for Atrial Fibrillation

   Heart rhythm·17 Sep 2026

More on GLP-1 receptor agonists

1. GLP-1 receptor agonists lower the risk of atrial fibrillation recurrence in humans (HR 0.52, 95% CI 0.37-0.73).

   Reviewafter catheter ablation

   Association of glucagon-like peptide-1 receptor agonists with atrial fibrillation recurrence after catheter ablation: a systematic review and meta-analysis

   Frontiers in cardiovascular medicine·27 Aug 2026

More on GLP-1 receptor agonists

1. Weight loss lowers the risk of atrial fibrillation recurrence in humans (RR 0.53).

   Reviewstructured, physician-led risk-factor program12-month

   The Effect of Weight Loss and Metabolic Interventions on Recurrence After Atrial Fibrillation Ablation

   Journal of clinical medicine·21 Aug 2026

More on Weight loss